| Also known as |
Fluoromethalone |
| Blood pressure |
Generally has minimal effect on blood pressure |
| Chemical name |
9-Fluoro-11ОІ,17-dihydroxy-6О±-methylpregna-1,4-diene-3,20-dione |
| Dosage (medical) |
Typically 0.1% topical ointment or suspension applied 2-4 times daily depending on the condition being treated |
| Dosage (sports) |
Not applicable for performance enhancement |
| Effects |
Reduces inflammation and immune responses |
| Formula |
C22H29FO5 |
| Half-life |
1.3 to 1.7 hours |
| Hepatotoxicity |
Low |
| Lab Test |
Specific tests for monitoring corticosteroid levels are available but not commonly required for fluorometholone specifically |
| Main action |
Anti-inflammatory |
| Side effects |
Blurred vision, eye pain, eye irritation, increased intraocular pressure, possible systemic effects with prolonged use |
| Storage conditions |
Store at room temperature, avoid freezing and protect from light |
| Strength |
1 mg |
| Substance class |
Corticosteroid |
| Trade name |
Flarex, FML, Efemoline |
| Use in sports |
Not typically used for performance enhancement, may be used therapeutically for inflammation control under medical supervision |
| Water Retention |
Minimal |
| Manufacturer |
Allergan |
